| Title | [Smoking cessation with Nicotine replacement therapy (NRT) - a scientific Update.] | | Author(s) | Mulzer KH, Lichtenschopf A, Homeier I, Groman E | | Institution | Johnson & Johnson GmbH, Neuss, Germany. | | Source | Wien Med Wochenschr 2009; 159(1-2):25-32. | | Abstract | Nicotine replacement therapy (NRT) is available in various application forms for the treatment of tobacco addiction. All forms underwent a comprehensive clinical study program (approx. 132 trial) to research on efficacy, safety and influence of environmental conditions. Nicotine gum, patch, nasalspray, microtab, lozenge and inhaler are recommended based on evidence criteria (OR 1.5 to 3.6, variation based on usage conditions and application form. NRT forms are OTC medicines (Exception: Nicotine nasalspray). The quality and the certainty of the nicotine replacement therapy will be enhanced by reflecting considerations concerning the indication, correlation of single NRT form to the appropriate user as well as the right dosage and compliance matters. | | Language | ger | | Pub Type(s) | English Abstract
Journal Article
| | PubMed ID | 19225732 |
|
